PK

Purushottam Kishanchand Lakhani

Active Director Director DIN 09155541
DIN 09155541 First appointment Apr 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Purushottam Kishanchand Lakhani

Data last updated:

Purushottam Kishanchand Lakhani is a Director at Uniservo Medex Private Limited (since 2021). The company operates in Pharma.

DIN 09155541
Primary Designation Director
Industry Pharma
First Appointment 22 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Uniservo Medex Private Limited U24239MH2021PTC359417
Director22 Apr 20212021Active

Board colleagues of Purushottam Kishanchand Lakhani

NameDINCompanyDesignation
Sunil Parasram Bokde09155540Uniservo Medex Private LimitedDirector

Directorship timeline

Open interactive timeline →
Uniservo Medex Private Limited
Premium access

Shareholding and investment profile for Purushottam Kishanchand Lakhani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Purushottam Kishanchand Lakhani

Purushottam Kishanchand Lakhani currently holds 1 directorship: Uniservo Medex Private Limited (Director, since 22 Apr 2021).

Purushottam Kishanchand Lakhani was first appointed on 22 Apr 2021 as Director at Uniservo Medex Private Limited.

The current boards of Purushottam Kishanchand Lakhani's companies include Sunil Parasram Bokde (Uniservo Medex Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available